Endurant Capital Management’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-30,591
| Closed | -$106K | – | 59 |
|
|
2022
Q2 | $106K | Sell |
30,591
-99,976
| -77% | -$346K | 0.04% | 47 |
|
|
2022
Q1 | $1.48M | Sell |
130,567
-53,976
| -29% | -$610K | 0.39% | 45 |
|
|
2021
Q4 | $1.77M | Sell |
184,543
-905
| -0.5% | -$8.66K | 0.43% | 40 |
|
|
2021
Q3 | $1.64M | Buy |
185,448
+8,300
| +5% | +$73.4K | 0.37% | 42 |
|
|
2021
Q2 | $2.17M | Buy |
177,148
+45,352
| +34% | +$556K | 0.6% | 45 |
|
|
2021
Q1 | $2.1M | Sell |
131,796
-6,817
| -5% | -$109K | 0.55% | 48 |
|
|
2020
Q4 | $2.12M | Buy |
138,613
+27,702
| +25% | +$423K | 0.76% | 39 |
|
|
2020
Q3 | $2.06M | Buy |
+110,911
| New | +$2.06M | 0.61% | 40 |
|